Since C. difficile infection has been shown to be a marker of debility and death in LTC residents, it is critical that the treatment team develop an understanding of the scope of the problem, as well as effective preventive measures and new treatment regimens. This webinar will review the increasing dilemma of Clostridium difficile infection in long-term care. This activity will focus on prevention of infection with a discussion on the critical role of normal gut flora, antibiotic stewardship, and hand/environmental hygiene. The presenter will review literature on newer treatments of Clostridium difficile infection, including the practical and regulatory impact of fecal transplant.
Disclosure: Dr. Archbald-Pannone has no relevant financial relationships to disclose.
Conflicts of Interest: The planners and presenters of this CNE activity have disclosed no relevant financial relationships with any commercial companies pertaining to this activity.
Non-Endorsement of Products: The Maryland Nurses Association's accredited-provider status refers only to continuing nursing education activities and does not imply that there is real or implied endorsement by of any product, service, or company referred to in this activity nor of any company subsidizing costs related to the activity.
Off-label Product Use: This educational activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).
Learning Objectives: The overall goal of this activity is to enhance participants’ knowledge and competency in treating patients with Clostridium difficile infection(s) by reviewing the most recent updates and tools available to practitioners.
Upon completion of this activity, participants should be able to:
Recognize the impact of Clostridium difficile infection on residents in long-term care.
Examine the current literature on the effect of intestinal flora on Clostridium difficile infection and impact of antibiotic use.
Describe the literature for newer treatments for Clostridium difficile infection, including regulations and procedures.